{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:22:43Z","timestamp":1777180963292,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40265-016-0559-2","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T09:40:50Z","timestamp":1456998050000},"page":"501-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dichlorphenamide: A Review in Primary Periodic Paralyses"],"prefix":"10.1007","volume":"76","author":[{"given":"Sarah L.","family":"Greig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"559_CR1","author":"V Sansone","year":"2008","unstructured":"Sansone V, Meola G, Links TP, et al. Treatment for periodic paralysis. Cochrane Database Syst Rev. 2008. doi: 10.1002\/14651858.CD005045.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"559_CR2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/WCO.0b013e32832efa8f","volume":"22","author":"D Platt","year":"2009","unstructured":"Platt D, Griggs R. Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias. Curr Opin Neurol. 2009;22(5):524\u201331.","journal-title":"Curr Opin Neurol"},{"key":"559_CR3","doi-asserted-by":"crossref","unstructured":"Statland JM, Barohn RJ. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses. Continuum. 2013;19(6 Muscle Disease):1598\u2013614.","DOI":"10.1212\/01.CON.0000440661.49298.c8"},{"key":"559_CR4","unstructured":"Taro Pharmaceuticals USA Inc. Keveyis\u2122 (dichlorphenamide) tablets, for oral use: US prescribing information. 2015. http:\/\/www.fda.gov . Accessed 25 Feb 2016."},{"key":"559_CR5","unstructured":"Taro Pharmaceuticals Industries Ltd. FDA approves Keveyis (dichlorphenamide) for primary hyperkalemic and hypokalemic periodic paralysis [media release]. 10 Aug 2015. http:\/\/www.drugs.com\/newdrugs ."},{"issue":"150","key":"559_CR6","first-page":"43645","volume":"72","author":"US Food and Drug Administration","year":"2007","unstructured":"US Food and Drug Administration. Determination that Daranide (dichlorphenamide) tablets, 50 milligrams, were not withdrawn from sale for reasons of safety or effectiveness. Fed Regist. 2007;72(150):43645.","journal-title":"Fed Regist."},{"issue":"Pt 11","key":"559_CR7","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1113\/jphysiol.2009.186627","volume":"588","author":"E Matthews","year":"2010","unstructured":"Matthews E, Hanna MG. Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis? J Physiol. 2010;588(Pt 11):1879\u201386.","journal-title":"J Physiol"},{"key":"559_CR8","doi-asserted-by":"crossref","unstructured":"Tricarico D, Mele A, Calzolaro S, et al. Emerging role of calcium-activated potassium channel in the regulation of cell viability following potassium ions challenge in HEK293 cells and pharmacological modulation. PLoS One. 2013;8(7):[article no. e69551].","DOI":"10.1371\/journal.pone.0069551"},{"issue":"1","key":"559_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nmd.2005.10.005","volume":"16","author":"D Tricarico","year":"2006","unstructured":"Tricarico D, Mele A, Conte Camerino D. Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+-channels. Neuromuscul Disord. 2006;16(1):39\u201345.","journal-title":"Neuromuscul Disord"},{"key":"559_CR10","author":"VA Sansone","year":"2016","unstructured":"Sansone VA, Burge J, McDermott MP, et al. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology. 2016. doi: 10.1212\/WNL.0000000000002416 .","journal-title":"Neurology."},{"issue":"1","key":"559_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H","volume":"47","author":"R Tawil","year":"2000","unstructured":"Tawil R, McDermott MP, Brown R Jr, et al. Randomized trials of dichlorphenamide in the periodic paralyses. Ann Neurol. 2000;47(1):46\u201353.","journal-title":"Ann Neurol."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-016-0559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-016-0559-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-016-0559-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T06:05:48Z","timestamp":1567663548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-016-0559-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s40265-016-0559-2","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}